Anna Porwit‐MacDonald

Author

Also Known As

A Porwit-MacDonald, A. Porwit-MacDonald, A. Porwit‐MacDonald, Anna Porwit-MacDonald, Anna Porwit-Macdonald, Anna Porwit-macdonald, Anna Porwit‐MacDonald, Anna Porwit‐Macdonald

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet Lund University University College London Erasmus University Rotterdam

About

Anna Porwit‐MacDonald is an author at Karolinska University Hospital specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.4K
2	Health Sciences	7	7	730
3	Cell Biology	6	6	637
4	Public Health	1	1	189
5	Biostatistics	1	1	189

Anna Porwit‐MacDonald

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype Karin E. Smedby, Henrik Hjalgrim, Johan Askling, JNCI Journal of the National Cancer Institute	2006	434
Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas Karin E. Smedby, Henrik Hjalgrim, Mads Melbye, JNCI Journal of the National Cancer Institute	2005	257
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Paulo Lúcio, A Parreira, MWM van den Beemd, Leukemia Flow Cytometric AnalysisLymphoid NeoplasiaAutoimmune DiseaseMalignant Blood DisorderImmunology	1999	234
Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF Martin Jädersten, Scott Montgomery, Ingunn Dybedal, Blood	2005	203
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status A. Andersson, Christian Ritz, David Lindgren, Leukemia Hematological MalignancyMicroarray-based ClassificationConsecutive SeriesChildhood Acute LeukemiasMedicine	2007	189
The WHO classification of MDS does make a difference Robert B. Howe, Anna Porwit‐MacDonald, Robert Wanat, Blood	2003	147
BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings Paulo Lúcio, Giuseppe Gaipa, EG van Lochem, Leukemia Precursor B-allHematologyImmunologyStandardized Triple-stainingsImmunophenotyping	2001	138
Family History of Hematopoietic Malignancy and Risk of Lymphoma Ellen T. Chang, Karin E. Smedby, Henrik Hjalgrim, JNCI Journal of the National Cancer Institute	2005	132
BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL) Anna Porwit‐MacDonald, E. Björklund, Paulo Lúcio, Leukemia Hematological MalignancyCd7+ Cell SubsetsMixed-phenotype Acute LeukemiaMalignant Blood DisorderNormal Bone Marrow	2000	119
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia Jeanette Lundin, Anna Porwit‐MacDonald, Eva Rossmann, Leukemia Hematological MalignancyLymphoid NeoplasiaSubcutaneous AlemtuzumabAutoimmune DiseaseCellular Immune Reconstitution	2004	118

Page 1